(Q38176442)

30 August 2017

title

Adult adherent stromal cells in the management of graft-versus-host disease (English)

1 reference

30 August 2017

Laura F Newell

1

1 reference

30 August 2017

Robert J Deans

series ordinal

2

1 reference

30 August 2017

Richard T Maziarz

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

Expert Opinion on Biological Therapy

30 August 2017

published in

1 reference

30 August 2017

volume

14

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

231-246

1 reference

In vitro duplication and ‘cure’ of haemopoietic defects in genetically anaemic mice

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

W/Wv marrow stromal cells engraft and enhance early erythropoietic progenitors in unconditioned Sl/Sld murine recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

BCNU treatment of marrow stromal monolayers reversibly alters haematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Mesenchymal stem cells avoid allogeneic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Peak serum: implications of serum supply for cell therapy manufacturing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Assessing response of therapy for acute and chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

A biomarker panel for acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Elafin is a biomarker of graft-versus-host disease of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Genetics of graft-versus-host disease: the major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell t

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

A survey of diagnosis, management, and grading of chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.866648

10.1517/14712598.2014.866648

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference